ONWARD Medical B.V. Registered Aktie

4,56 EUR -0,14 EUR -2,98 %

28.03.2025

FSE

4,65 EUR -0,21 EUR -4,32 %

28.03.2025

ASX

Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!

JETZT LOSLEGEN

Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handeln Smartphone

Marktkap.207,60 Mio. EUR

Div. Rendite0,00%

WKNA3C5RE

ISINNL0015000HT4

SymbolONWRF

ONWARD Medical B.V. Registered Aktien News

Sortieren:Datum Meistgelesen

21.03.24GlobeNewswireONWARD® Medical Publishes Prospectus for Listing of New Shares

21.03.24GlobeNewswireONWARD® Medical Successfully Raises €20 Million in a Capital Increase by Way of an Accelerated Bookbuild Offering and by Way of a Public Offering in France

20.03.24GlobeNewswireONWARD® Medical Launches Capital Increase by Way of an Accelerated Bookbuild Offering and of a Public Offering in France for an Indicative Amount of EUR 15 Million, with an Up to EUR 5 Million Upsize

18.03.24GlobeNewswireONWARD® Medical Successfully Completes Benchmark Testing on Path to Commercialize ARC-EX® System

15.03.24GlobeNewswireONWARD® Medical Reaffirms Guidance, Shares 2024 Strategic Priorities, and Releases Unaudited Q4 Financial Highlights

11.03.24GlobeNewswireONWARD® Medical Accepted to New US FDA TAP Program for Development of its ARC-BCI™ System

29.02.24GlobeNewswireONWARD® Medical Awarded 10th Breakthrough Device Designation for Brain-Computer Interface (BCI) from US FDA

09.02.24GlobeNewswireKBC Securities Initiates Research Coverage of ONWARD® Medical with a Buy Rating and Target Price of EUR 10.00 Per Share

07.02.24GlobeNewswireONWARD® MEDICAL ANNOUNCES PRESENTATION AT BIOCAPITAL EUROPE

25.01.24GlobeNewswireONWARD® ARC Therapy™ Highlighted at 2024 Annual Meeting of the North American Neuromodulation Society (NANS)

22.01.24GlobeNewswireONWARD® to Participate in Basel Healthtech Conference 2024

19.01.24GlobeNewswireONWARD® to Participate in Degroof Petercam Healthcare Conference

18.01.24GlobeNewswireONWARD® Announces Start of HemON NL Clinical Study

16.11.23GlobeNewswireONWARD® Reports Q3 Business Update and Year-To-Date Highlights

06.11.23GlobeNewswireNature Medicine Publication Highlights Potential for ONWARD® ARC Therapy™ to Improve Mobility After Parkinson’s Disease

11.10.23GlobeNewswireONWARD Schedules Webcast to Provide Third Quarter 2023 Business Update

27.09.23GlobeNewswireONWARD® Announces First-in-Human Implant of ARC-IM™ Stimulator with Brain-Computer Interface (BCI) to Restore Arm, Hand, and Finger Function after Spinal Cord Injury

19.09.23GlobeNewswireONWARD® Reports 2023 Half Year Results and Business Update

13.09.23GlobeNewswireONWARD® Launches Partnership with Service-Disabled Veteran-Owned Business to Access U.S. Federal Health Market

06.09.23GlobeNewswireONWARD Schedules Webcast to Provide Half Year 2023 Business Update

24.05.23GlobeNewswireBrain Computer Interface (BCI) Enables Thought-Controlled Walking after Spinal Cord Injury

16.05.23GlobeNewswireONWARD Reports Q1 Business Update and Year-To-Date Highlights

15.05.23GlobeNewswireONWARD Announces First-in-Human Use of ARC-IM™ Lead to Restore Movement and Function after Spinal Cord Injury

08.05.23GlobeNewswireONWARD Announces Results of Annual General Meeting of Shareholders

03.05.23GlobeNewswireONWARD Schedules Webcast to Provide First Quarter Business Update

12.04.23GlobeNewswireONWARD to Attend Upcoming Scientific and Investor Events

30.03.23GlobeNewswireONWARD Publishes First Annual ESG Summary

27.03.23GlobeNewswireConvocation of the 2023 Annual General Meeting of Shareholders and Proposed Resolutions

27.03.23GlobeNewswireONWARD Reports 2022 Full Year Financial and Operating Results

14.03.23GlobeNewswireONWARD to Publish Full Year 2022 Financial Results and Host Webcast on March 28, 2023

13.03.23GlobeNewswireONWARD Does Not Hold Cash Deposits at Silicon Valley Bank

23.02.23GlobeNewswireONWARD Receives New FDA Breakthrough Device Designations for Bladder Control, Alleviation of Spasticity, and Blood Pressure Regulation after Spinal Cord Injury

08.12.22BusinesswireONWARD Reports Interim Clinical Outcomes for Implantable ARC Therapy Demonstrating Potential to Improve Blood Pressure Regulation after Spinal Cord Injury

21.11.22BusinesswireONWARD Awarded European Innovation Council Grant to Further Develop Brain-Computer Interface Technology; Company also Wins First Place in 2022 Brain-Computer Interface Awards

10.11.22BusinesswireONWARD’s Research Partner .NeuroRestore Publishes Groundbreaking Paper Identifying Neurons that Restore Walking after Paralysis

08.11.22BusinesswireONWARD Reports Third Quarter 2022 Highlights and Provides Business Update

ONWARD Medical B.V. Registered News

ONWARD Medical B.V. Registered News: auf dieser Seite finden Sie alle ONWARD Medical B.V. Registered News und Nachrichten zur ONWARD Medical B.V. Registered Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch ONWARD Medical B.V. Registered News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um ONWARD Medical B.V. Registered News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.